Walleye Capital
BIOA

Walleye Capital’s BioAge Labs BIOA Stock Holding History

Walleye Capital’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.69M Buy
354,395
+202,721
+134% +$3.66M 0.03% 541
2026
Q1 		$2.65M Buy
151,674
+16,879
+13% +$325K 0.01% 1242
2025
Q4 		$1.78M Buy
134,795
+121,902
+945% +$1.08M 0.01% 1964
2025
Q3 		$75.8K Sell
12,893
-2,600
-17% -$12.2K ﹤0.01% 3843
2025
Q2 		$64K Buy
+15,493
New +$62.4K ﹤0.01% 3958
2024
Q4 		– Sell
-76,875
Closed -$1.6M – 5696
2024
Q3 		$1.6M Buy
+76,875
New +$1.54M ﹤0.01% 2188

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Walleye Capital's BIOA Position: Q2 2026 in Review

Walleye Capital increased its BioAge Labs (BIOA) stake by 134% in Q2 2026, buying an estimated $3.66M and bringing the position to 354,395 shares worth $8.69M. The position accounts for 0.03% of the portfolio, ranked #541.

Walleye Capital first reported a position in BIOA in Q3 2024 and has held it in 6 quarters since. 151 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Walleye Capital held 354,395 shares of BioAge Labs worth $8.69M as of Q2 2026.
  • Walleye Capital bought 202,721 BioAge Labs shares in Q2 2026, an estimated $3.66M.
  • BioAge Labs made up 0.03% of Walleye Capital's portfolio in Q2 2026, its #541 holding.
  • Walleye Capital first reported a position in BioAge Labs in Q3 2024 and has held it in 6 quarters since.
  • 151 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.